Akebia Therapeutics AKBA
NASDAQ AKBA
$0.56 -0.02 (-3.95%)
At close: Oct 22, 2026 · 4:00 PM EDT

Akebia Therapeutics (AKBA) Long-Term Debt Issuances (2024 - 2025)

Updated

Akebia Therapeutics (AKBA) reported Long-Term Debt Issuances of $10 million for FY2025, down 77.8% from $45 million in FY2024.

Analysis

Akebia Therapeutics (AKBA) Long-Term Debt Issuances (2024 - 2025) Analysis & Trends

Dating back to FY2019, Akebia Therapeutics' Long-Term Debt Issuances record includes 4 years.

  • Long-Term Debt Issuances has a five-year compound annual growth rate of -12.9% (FY2020 to FY2025).
  • According to Business Quant data, Long-Term Debt Issuances came in at $45 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Akebia Therapeutics 150.49 Mn -518.99 Mn 38.70 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 10.00 Mn
Jun 30, 2024 8.00 Mn
Mar 31, 2024 37.00 Mn
API Access

Akebia Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=AKBA&period=max&api_key=YOUR_API_KEY